Protective effects of rosiglitazone on retinal neuronal damage in diabetic rats (Q42733746)

6 November 2017

Protective effects of rosiglitazone on retinal neuronal damage in diabetic rats (English)

1 reference

6 November 2017

1 reference

Peiyu Li

1

1 reference

6 November 2017

Xun Xu

2

1 reference

6 November 2017

Zhi Zheng

3

1 reference

6 November 2017

Bijun Zhu

4

1 reference

6 November 2017

Yuhua Shi

5

1 reference

6 November 2017

Kun Liu

6

1 reference

6 November 2017

20 May 2011

1 reference

6 November 2017

1 reference

6 November 2017

36

1 reference

6 November 2017

7

1 reference

6 November 2017

673-679

1 reference

Degeneration of retinal neuronal processes and pigment epithelium in the early stage of the streptozotocin-diabetic rats

6 November 2017

1 reference

https://api.crossref.org/works/10.3109%2F02713683.2011.572220

A new view of diabetic retinopathy: a neurodegenerative disease of the eye.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02713683.2011.572220

Death of retinal neurons in streptozotocin-induced diabetic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02713683.2011.572220

Neural apoptosis in the retina during experimental and human diabetes. Early onset and effect of insulin

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02713683.2011.572220

A role for the polyol pathway in the early neuroretinal apoptosis and glial changes induced by diabetes in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02713683.2011.572220

Diabetes has an additive effect on neural apoptosis in rat retina with chronically elevated intraocular pressure

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02713683.2011.572220

Expression of apoptosis markers in the retinas of human subjects with diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02713683.2011.572220

Lower somatostatin expression is an early event in diabetic retinopathy and is associated with retinal neurodegeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02713683.2011.572220

Expression of antiapoptotic and proapoptotic molecules in diabetic retinas

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02713683.2011.572220

Mitochondria- and caspase-dependent cell death pathway involved in neuronal degeneration in diabetic retinopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02713683.2011.572220

Rosiglitazone taken once daily provides effective glycaemic control in patients with Type 2 diabetes mellitus.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02713683.2011.572220

Rosiglitazone short-term monotherapy lowers fasting and post-prandial glucose in patients with type II diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02713683.2011.572220

Role of PPAR-gamma ligands in neuroprotection against glutamate-induced cytotoxicity in retinal ganglion cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02713683.2011.572220

Rosiglitazone and delayed onset of proliferative diabetic retinopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02713683.2011.572220

Peroxisome proliferator-activated receptor gamma is expressed in hippocampal neurons and its activation prevents beta-amyloid neurodegeneration: role of Wnt signaling.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02713683.2011.572220

Peroxisome-proliferator-activated receptor-gamma (PPARgamma) activation protects neurons from NMDA excitotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02713683.2011.572220

Peroxisome proliferator-activated receptor gamma up-regulates the Bcl-2 anti-apoptotic protein in neurons and induces mitochondrial stabilization and protection against oxidative stress and apoptosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02713683.2011.572220

Rosiglitazone acts as a neuroprotectant in retinal cells via up-regulation of sestrin-1 and SOD-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02713683.2011.572220

15d-PGJ2 and rosiglitazone suppress Janus kinase-STAT inflammatory signaling through induction of suppressor of cytokine signaling 1 (SOCS1) and SOCS3 in glia

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02713683.2011.572220

Retinal ganglion cells in diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02713683.2011.572220

Intravitreal injection of erythropoietin protects both retinal vascular and neuronal cells in early diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02713683.2011.572220

Impact of diabetic retinopathy on quantitative retinal nerve fiber layer measurement and glaucoma screening

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02713683.2011.572220

The Ins2Akita mouse as a model of early retinal complications in diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02713683.2011.572220

Apoptosis: biochemical aspects and clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02713683.2011.572220

Caspase activation in retinas of diabetic and galactosemic mice and diabetic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02713683.2011.572220

Peroxisome proliferator-activated receptor-gamma agonists induce neuroprotection following transient focal ischemia in normotensive, normoglycemic as well as hypertensive and type-2 diabetic rodents

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02713683.2011.572220

SOCS 3 and PPAR-gamma ligands inhibit the expression of IL-6 and TGF-beta1 by regulating JAK2/STAT3 signaling in pancreas

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02713683.2011.572220

JAK2 and STAT3 activation contributes to neuronal damage following transient focal cerebral ischemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02713683.2011.572220

Role of NADPH oxidase and Stat3 in statin-mediated protection against diabetic retinopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02713683.2011.572220

Inhibition of JAK2/STAT3-mediated VEGF upregulation under high glucose conditions by PEDF through a mitochondrial ROS pathway in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02713683.2011.572220

Inhibitors of cytokine signal transduction

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02713683.2011.572220

Growth hormone preferentially induces the rapid, transient expression of SOCS-3, a novel inhibitor of cytokine receptor signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02713683.2011.572220

SOCS3 is a critical physiological negative regulator of G-CSF signaling and emergency granulopoiesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02713683.2011.572220

Suppressor of cytokine signalling (SOCS)-3 protects beta cells against IL-1beta-mediated toxicity through inhibition of multiple nuclear factor-kappaB-regulated proapoptotic pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02713683.2011.572220

Suppressor of cytokine signalling-3 inhibits Tumor necrosis factor-alpha induced apoptosis and signalling in beta cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02713683.2011.572220

Induction of suppressors of cytokine signaling (SOCS) in the retina during experimental autoimmune uveitis (EAU): potential neuroprotective role of SOCS proteins.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02713683.2011.572220

Suppressors of cytokine-signaling proteins induce insulin resistance in the retina and promote survival of retinal cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02713683.2011.572220

Suppressor of cytokine signaling 3 (SOCS-3) protects beta -cells against interleukin-1beta - and interferon-gamma -mediated toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02713683.2011.572220

Ladostigil prevents gliosis, oxidative-nitrative stress and memory deficits induced by intracerebroventricular injection of streptozotocin in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02713683.2011.572220

10.3109/02713683.2011.572220

21 January 2018

Identifiers

DOI

1 reference

6 November 2017

1 reference